
JMS Co.,Ltd.
7702.TJPXHealthcareMedical - Instruments & Supplies
Latest quote
¥460
−¥2.00 · -0.43%
7702.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteJMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Ryuji Katsura
- Listed since
- Jan 4, 2001
- Employees
- 4,887
Market position
Day range
Current ¥460
52-week range
Current ¥460
- Open
- ¥463
- Previous close
- ¥462
- Volume
- 15.2K
- 0.48× average
- Average volume
- 31.77K
- Average daily volume
- Market cap
- 11.28B JPY
- Beta
- 0.26
- Market reference 1
- 50-day average
- ¥453.38
- +1.46% above average
- 200-day average
- ¥440.48
- +4.43% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 30.71B JPY
- EV / EBITDA
- 7.28×
- Earnings yield
- -7.52%
- Free cash flow yield
- -8.56%
Profitability & efficiency
- Return on equity
- -1.88%
- Return on assets
- -0.94%
- Return on invested capital
- 0.54%
Financial health
- Current ratio
- 1.78×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 65.85B JPY | 69.75B JPY | 65.29B JPY | 63.74B JPY | 58.17B JPY |
| Cost of goods sold | 50.49B JPY | 53.82B JPY | 51.2B JPY | 49.15B JPY | 43.9B JPY |
| Gross profit | 15.36B JPY | 15.93B JPY | 14.09B JPY | 14.6B JPY | 14.27B JPY |
| Research and development | — | — | 1.52B JPY | 1.32B JPY | 1.53B JPY |
| Selling, general, and administrative | 14.97B JPY | 15.05B JPY | 12.45B JPY | 12.12B JPY | 11.37B JPY |
| Operating expenses | 14.97B JPY | 15.05B JPY | 14.36B JPY | 13.87B JPY | 13.29B JPY |
| Interest income | 31M JPY | 19M JPY | 14M JPY | 12M JPY | 7M JPY |
| Interest expense | 407M JPY | 340M JPY | 220M JPY | 167M JPY | 159M JPY |
| Depreciation and amortization | 3.83B JPY | 3.89B JPY | 3.71B JPY | 3.59B JPY | 3.36B JPY |
| Operating income | 383M JPY | 874M JPY | −268M JPY | 724M JPY | 980M JPY |
| Net income | −784M JPY | 89M JPY | −36M JPY | 281M JPY | 826M JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- -15.48
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Sep 27, 2017 | 1:2 | — | — |
Effective Sep 27, 2017
1:2
7702.T peers
ETFs holding 7702.T
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T24.95M0.00%2.89T JPY0.05%¥418.3+0.07%
Dimensional - International Small Cap Value ETFDISV54.54K0.00%5.23B USD0.42%$44.49+0.86%
Dimensional - International Core Equity 2 ETFDFIC50.63K0.00%15.43B USD0.22%$39.405+0.83%
Dimensional World ex U.S. Core Equity 2 ETFDFAX29.42K0.00%12.57B USD0.28%$38.16+0.82%
Dimensional - International Small Cap ETFDFIS9.23K0.00%5.91B USD0.39%$37.545+0.71%
iShares Core TOPIX ETF1475.T- Market value
- 24.95M
- Weight
- 0.00%
- AUM
- 2.89T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥418.3+0.07%
Dimensional - International Small Cap Value ETFDISV- Market value
- 54.54K
- Weight
- 0.00%
- AUM
- 5.23B USD
- Expense ratio
- 0.42%
- Price / 1D
- $44.49+0.86%
Dimensional - International Core Equity 2 ETFDFIC- Market value
- 50.63K
- Weight
- 0.00%
- AUM
- 15.43B USD
- Expense ratio
- 0.22%
- Price / 1D
- $39.405+0.83%
Dimensional World ex U.S. Core Equity 2 ETFDFAX- Market value
- 29.42K
- Weight
- 0.00%
- AUM
- 12.57B USD
- Expense ratio
- 0.28%
- Price / 1D
- $38.16+0.82%
Dimensional - International Small Cap ETFDFIS- Market value
- 9.23K
- Weight
- 0.00%
- AUM
- 5.91B USD
- Expense ratio
- 0.39%
- Price / 1D
- $37.545+0.71%
Continue in GoAI
Research 7702.Tresearch.disclaimer





